# Lymph Node Ratio and Kras Mutation in R Colon Cancer

> **NCT04342676** · PHASE3 · COMPLETED · sponsor: **Mansoura University** · enrollment: 433 (actual)

## Conditions studied

- Colon Cancer Stage III

## Interventions

- **DEVICE:** k ras
- **DRUG:** Panitumumab

## Key facts

- **NCT ID:** NCT04342676
- **Lead sponsor:** Mansoura University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-03-10
- **Primary completion:** 2019-08-25
- **Final completion:** 2019-08-26
- **Target enrollment:** 433 (ACTUAL)
- **Last updated:** 2020-04-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04342676

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04342676, "Lymph Node Ratio and Kras Mutation in R Colon Cancer". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT04342676. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*